Moldova - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Moldova Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases decreased by 0% year on year. In 2019, the country was number 49 comparing other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases at 924 Cases. Moldova is overtaken by Tajikistan, which was number 48 with 944 Cases and is followed by Democratic Republic of the Congo with 918 Cases. India lead the ranking with 66,255 Cases in 2019, +13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia recorded the worst performance at -100% per year.
Loading...
Date | Units (Cases) |
---|---|
2019 | 924.00 |
2018 | 919.00 |
2017 | 853.00 |
2016 | 1,031.00 |
2015 | 1,042.00 |
How does Moldova rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
# | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
48 |
#48
Tajikistan
|
944 | 2019 | +3.1 % | +0.9 % | View data | |
49 |
#49
Moldova
|
924 | 2019 | +0.5 % | -0.0 % | View data | |
51 |
#51
South Korea
|
903 | 2019 | +1.6 % | -5.1 % | View data |